Media

Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware

November 7, 2024

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including reports of deaths and hospitalizations, while working with the FDA to resolve issues.

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including reports of deaths and hospitalizations, while working with the FDA to resolve issues.
read more

This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.

Related News

STEPHEN MOORE: Why Moody’s credibility should be questioned after downgrade of US federal bonds

Klarna doubles losses in first quarter as IPO remains on hold

Drink company that sells Guinness and Johnnie Walker sees $150M profit hit from tariffs

You may have missed

STEPHEN MOORE: Why Moody’s credibility should be questioned after downgrade of US federal bonds

Bitcoin’s Volatile Liquidity Run Could Lead to New Record Highs

Strategy Expands Bitcoin Holdings With Latest Multi-Million Dollar Purchase

Ethereum’s Vitalik Buterin Proposes Design to Make Running Nodes Easier